Back to Results
First PageMeta Content
Financial economics / Shareholder rights plan / Bill Ackman / Martin Lipton / Allergan / Wachtell /  Lipton /  Rosen & Katz / Takeover / Corporate raid / Corporate law / Mergers and acquisitions / Business / Investment


Did Bill Ackman just kill the poison pill? Fortune By Stephen Gandel November 6, 2014 The Valeant-Allergan fight shows that hedge fund activists are getting better at swallowing
Add to Reading List

Document Date: 2014-11-07 11:52:31


Open Document

File Size: 87,07 KB

Share Result on Facebook

Company

Allergan / Ackman / Wachtell Lipton Rosen / Activas / Valeant / /

Country

Columbia / /

Event

M&A / Business Partnership / /

Facility

Circuit Court of Appeals / Delaware court / Columbia University / /

IndustryTerm

rival pharmaceuticals / defense tool / botox maker / pharmaceutical / law / /

NaturalFeature

Delaware / /

Organization

Columbia University / Delaware court / UN Court / Harvard / Court of Appeals in New York / /

Person

Bill Ackman / Marty Lipton / Carl Icahn / Fortune By Stephen Gandel / Lucian Bebchuk / /

Position

legendary corporate lawyer / professor / law professor / head / judge / legendary corporate lawyer and the long-time head / /

ProvinceOrState

Delaware / California / /

SocialTag